UNH Stock Price Today (June 2026) — UnitedHealth Group Incorporated Analysis & Key Metrics 2026-06-16
UnitedHealth Group Incorporated (UNH) is trading at $407.65, down 0.82% today (as of June 2026). The stock continues to show sustained strength above key moving averages, attracting attention from investors looking for Healthcare growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $404.85 (-0.7% upside).
- Volatility remains elevated (21.50% annualized), implying wide price swings for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: solid revenue growth (2.00% YoY) alongside significant competitive pressures.
UNH Stock Analysis: Key Metrics & Valuation (June 2026)
Concise, actionable data for investors
UnitedHealth Group Incorporated - Historical Price & Volume
Market Cap
Enterprise Value: $423.35B
P/E Ratio
Forward P/E: 19.45
Revenue Growth
Year over Year
Analyst Target
+-0.7% upside potential
Key Investor Questions About UNH
What investors need to know before buying
Based on current market data, UNH presents a neutral technical setup with caution warranted fundamentals.
- Technicals say: Neutral (RSI 66.15)
- Fundamentals say: Caution warranted (high leverage concerns)
UNH's growth trajectory depends on its ability to expand within the Healthcare Plans sector while managing margin pressures.
- Future growth will depend on performance in core Healthcare Plans operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for UNH investors include debt exposure and competitive dynamics in the Healthcare Plans industry.
- $77.92B in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Healthcare Plans.
52-Week Trading Range
Over the past year, UNH stock traded between $234.60 and $408.71—recovering meaningfully from lows and currently near the higher end. Big swings are likely unless a major catalyst emerges.
Volatility & Risk Profile
With 21.50% annualized volatility and β=0.35, the stock exhibits low sensitivity to market moves—making UNH suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
High institutional backing, but elevated short interest signals a potential battleground stock.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines and coverage
Why Did UnitedHealth Stock Choose Pain Over Growth?
Long before the stock surged, the company had been openly broadcasting its decision to choose profit over scale. The market initially ignored the signal - until the turnaround became undeniable.
Many Hedge Funds Bought Up This Stock Last Quarter — And You’ve Probably Never Heard of It
Every once in a while, the hedge funds start circling one surprising company that few retail investors have ever even heard of. Undoubtedly, the list of hedge fund favorites hasn’t really changed all too much in the past year. Whether we’re talking about the hard-hit hyperscalers or UnitedHealth Group (NYSE:UNH), the list of hedge fund ... Many Hedge Funds Bought Up This Stock Last Quarter — And You’ve Probably Never Heard of It
3 Dividend Increases Investors Can Actually Trust
UnitedHealth, Caterpillar, and Donaldson raised quarterly dividends by 5%, 8%, and 6.7%, respectively, with earnings coverage indicating sustainable payouts for all three companies.
Healthcare Added 35,200 Jobs—3 Stocks Positioned to Benefit
Healthcare added 35,200 jobs in May, supporting growth opportunities for healthcare stocks that are positioned for the underlying trends
Beat the Market Like Zacks: FirstCash, Cisco, Bread Financial in Focus
FCFS, CSCO and BFH led standout gains as Zacks highlighted top-performing portfolios amid volatile markets and inflation worries.
Jim Cramer on UnitedHealth: “Buy It”
UnitedHealth Group Incorporated (NYSE:UNH) was among the stocks Jim Cramer highlighted during Mad Money, as he noted the rotation into defensive sectors. Cramer called the company’s CEO “legendary,” as he commented: Finally, we have UnitedHealth. It’s another managed care play that’s up for the same reason as Humana. The stock pulled back this afternoon, but […]
JPMorgan Raises its Price Target on UnitedHealth Group (UNH)
UnitedHealth Group Incorporated (NYSE:UNH) is one of the 7 Best Longevity Stocks to Buy Now. On June 8, 2026, JPMorgan raised the firm’s price target on UnitedHealth Group Incorporated (NYSE:UNH) to $466 from $420 and maintained an Overweight rating on the shares. JPMorgan updated its healthcare service models. On the same day, Mizuho raised the […]
UnitedHealth, FTC reach proposed settlement in insulin case
The tentative deal comes months after CVS reached a proposed settlement in the lawsuit alleging major PBMs are inflating insulin costs. Cigna has already settled with the FTC.
Patients Denied Care, Then Approved Later? Federal Watchdog Raises Medicare Advantage Concerns
Federal investigators raised concerns about how Medicare Advantage plans handle requests for post-hospital recovery care, finding that many denials were later overturned on appeal. Two reports from the Office of Inspector General at the Department of Health and Human Services...
Did Dividend Hike and Rejected Independent Chair Just Shift UnitedHealth Group's (UNH) Investment Narrative?
Earlier this month, UnitedHealth Group held its 2026 annual shareholder meeting, reported voting results that rejected an independent board chair proposal, and approved a quarterly cash dividend of US$2.32 per share payable on June 23 to shareholders of record on June 15. These governance and capital return decisions arrive as UnitedHealth’s Medicare-focused recovery, cost-control progress, and dividend track record are drawing renewed attention from analysts and income-oriented...
Frequently Asked Questions
Common investor questions about UnitedHealth Group Incorporated
UnitedHealth Group Incorporated (UNH) is currently trading at $407.65. The RSI (14-day) is at 66.2, indicating neutral territory. Wall Street analysts have a consensus "buy" recommendation. The mean analyst price target of $404.85 implies 0.7% downside from current levels. Volatility is moderate at 21.5% annualized, meaning price movements are relatively contained. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for UnitedHealth Group Incorporated (UNH): The trailing P/E ratio is 30.67, which is above the market average, indicating investors are pricing in higher growth expectations. The forward P/E is 19.45, lower than the trailing P/E, suggesting analysts expect earnings improvement. The PEG ratio is 1.38, near 1.0, suggesting roughly fair value relative to growth. Price-to-Book is 3.78. Price-to-Sales is 0.82. Valuation should be compared to Healthcare Plans industry peers for context, as different sectors trade at different multiples.
Based on 26 analysts covering UNH, the consensus price target is $404.85. This represents a 0.7% downside from the current price of $407.65. The range spans from a low target of $287.00 to a high target of $492.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "buy". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Yes, UnitedHealth Group Incorporated (UNH) pays a dividend with a current yield of approximately 2.28%. The annualized dividend rate is $8.84 per share. The payout ratio is 66.6%, which is moderate and suggests adequate earnings coverage for the dividend. The most recent ex-dividend date was 2026-06-15T00:00:00.000Z.
Key risks for UnitedHealth Group Incorporated (UNH) investors include: 1. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 2. Healthcare Plans sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is UnitedHealth Group Incorporated's (UNH) current debt and financial health profile: Total debt stands at $77.92B. The debt-to-equity ratio is 73.98, which is moderate and generally manageable for most companies. The current ratio is 0.80, which is below 1.0 and may indicate short-term liquidity concerns. The quick ratio is 0.72. The company holds $31.23B in cash and equivalents. Free cash flow is positive at $17.69B, providing a cushion for debt servicing and shareholder returns.